• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组人结肠癌细胞系中RON受体酪氨酸激酶的过表达与激活

Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.

作者信息

Chen Y Q, Zhou Y Q, Angeloni D, Kurtz A L, Qiang X Z, Wang M H

机构信息

Department of Medicine, University of Colorado School of Medicine and Denver Health Medical Center, Denver, Colorado 80204, USA.

出版信息

Exp Cell Res. 2000 Nov 25;261(1):229-38. doi: 10.1006/excr.2000.5012.

DOI:10.1006/excr.2000.5012
PMID:11082293
Abstract

RON is a receptor tyrosine kinase belonging to the MET proto-oncogene family. The purposes of this study are to determine the expression and activation of RON in a panel of human colon carcinoma cell lines. Western blotting showed that RON is barely detectable in normal and SV-40-transformed colon epithelial cells, but highly expressed and constitutively activated in several colon carcinoma cell lines including Colo201, HT-29, HCT116, and SW837. Moreover, a novel RON variant with a molecular mass of 160 kDa (RONDelta160) was identified from HT-29 cells. The cDNA encoding RONDelta160 has an in-frame deletion of 109 amino acids in the extracellular domain of the RON beta chain, which is caused by splicing out of two exons in the RON mRNA. No mutations were found in the kinase domain of the RON gene in five carcinoma cell lines screened. By expressing RON in colon epithelial cells, we found that RON activation increases cell motile-invasive activities and protects cells against apoptotic death. These data suggest that RON expression and activation are deregulated in colon carcinoma cell lines. By abnormal activation of RON, this receptor and its variant may regulate motile-invasive phenotypes of certain colon carcinoma cells in vivo.

摘要

RON是一种属于MET原癌基因家族的受体酪氨酸激酶。本研究的目的是确定RON在一组人结肠癌细胞系中的表达和激活情况。蛋白质印迹法显示,在正常和SV - 40转化的结肠上皮细胞中几乎检测不到RON,但在包括Colo201、HT - 29、HCT116和SW837在内的几种结肠癌细胞系中高表达且组成性激活。此外,从HT - 29细胞中鉴定出一种分子量为160 kDa的新型RON变体(RONDelta160)。编码RONDelta160的cDNA在RONβ链的胞外结构域有109个氨基酸的框内缺失,这是由RON mRNA中两个外显子的剪接缺失导致的。在筛选的五个癌细胞系中,RON基因的激酶结构域未发现突变。通过在结肠上皮细胞中表达RON,我们发现RON激活增加细胞的运动侵袭活性并保护细胞免于凋亡死亡。这些数据表明,在结肠癌细胞系中RON的表达和激活失调。通过RON的异常激活,该受体及其变体可能在体内调节某些结肠癌细胞的运动侵袭表型。

相似文献

1
Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.一组人结肠癌细胞系中RON受体酪氨酸激酶的过表达与激活
Exp Cell Res. 2000 Nov 25;261(1):229-38. doi: 10.1006/excr.2000.5012.
2
Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells.人结肠癌细胞中RON受体酪氨酸激酶新剪接产物的鉴定
Carcinogenesis. 2000 Aug;21(8):1507-12.
3
Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential.原发性人类结肠直肠癌中RON受体酪氨酸激酶的表达改变:不同剪接的RON变体的产生及其致癌潜力。
Oncogene. 2003 Jan 16;22(2):186-97. doi: 10.1038/sj.onc.1206075.
4
Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain.通过一种在酪氨酸激酶结构域有缺陷的剪接RON受体变体来阻断结肠癌细胞的致瘤活性。
Cancer Biol Ther. 2007 Jul;6(7):1121-9. doi: 10.4161/cbt.6.7.4337.
5
Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.Ron的点突变和过表达会诱导细胞转化、肿瘤形成和转移。
Oncogene. 2001 Sep 27;20(43):6142-51. doi: 10.1038/sj.onc.1204836.
6
A novel variant of the RON receptor tyrosine kinase derived from colorectal carcinoma cells which lacks tyrosine phosphorylation but induces cell migration.源自结直肠癌细胞的 RON 受体酪氨酸激酶的一种新型变体,其缺乏酪氨酸磷酸化但能诱导细胞迁移。
Exp Cell Res. 2012 Dec 10;318(20):2548-58. doi: 10.1016/j.yexcr.2012.08.006. Epub 2012 Sep 7.
7
Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa.RON受体酪氨酸激酶及其剪接变体在人恶性和非恶性结肠黏膜中的存在情况。
Int J Oncol. 1999 Oct;15(4):709-14. doi: 10.3892/ijo.15.4.709.
8
Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase.在免疫球蛋白-神经丛素转录(IPT)结构域中的缺失或插入可调节 RON 受体酪氨酸激酶的表达和致瘤活性。
Mol Cancer. 2010 Nov 29;9:307. doi: 10.1186/1476-4598-9-307.
9
RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.RON受体酪氨酸激酶的RNA介导基因沉默改变了人类结肠癌细胞的致癌表型。
Oncogene. 2004 Nov 4;23(52):8464-74. doi: 10.1038/sj.onc.1207907.
10
STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.STK/RON受体酪氨酸激酶通过HGF受体家族中保守的多功能对接位点介导凋亡信号和生长信号。
EMBO J. 1996 Nov 1;15(21):5866-75.

引用本文的文献

1
MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence.MSP-RON信号通路在肝脏病理生物学中的作用及作为新兴治疗靶点的研究现状:现有证据综述
Cell Commun Signal. 2025 Aug 28;23(1):385. doi: 10.1186/s12964-025-02407-5.
2
MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation.MAGOH通过抑制hnRNPA1表达介导的RONΔ160/PI3K/AKT信号通路激活促进胃癌进展。
J Exp Clin Cancer Res. 2024 Jan 25;43(1):32. doi: 10.1186/s13046-024-02946-8.
3
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
靶向 RON 激酶(MST1R)异构体可提高抗肿瘤疗效。
Cell Death Differ. 2023 Dec;30(12):2491-2507. doi: 10.1038/s41418-023-01235-9. Epub 2023 Nov 6.
4
The Promoter Region of the Proto-Oncogene MST1R Contains the Main Features of G-Quadruplexes Formation.原癌基因 MST1R 的启动子区域包含 G-四链体形成的主要特征。
Int J Mol Sci. 2022 Oct 26;23(21):12905. doi: 10.3390/ijms232112905.
5
The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies.癌症中的MST1R/RON酪氨酸激酶:致癌功能与治疗策略
Cancers (Basel). 2022 Apr 18;14(8):2037. doi: 10.3390/cancers14082037.
6
CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways.CCL20通过自分泌HGF-c-Met和MSP-MSPR信号通路诱导结直肠癌肿瘤上皮细胞增殖、迁移,并进一步产生CCL20。
Oncotarget. 2021 Nov 23;12(24):2323-2337. doi: 10.18632/oncotarget.28131.
7
EGFR transactivates RON to drive oncogenic crosstalk.EGFR 反式激活 RON 以驱动致癌性串扰。
Elife. 2021 Nov 25;10:e63678. doi: 10.7554/eLife.63678.
8
MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).MSP-RON信号通路在胰腺上皮内瘤变(PanIN)向胰腺导管腺癌(PDAC)转变过程中被激活。
Front Physiol. 2019 Feb 26;10:147. doi: 10.3389/fphys.2019.00147. eCollection 2019.
9
Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.利用噬菌体展示技术鉴定RON酪氨酸激酶受体结合肽及其结合模式的计算建模
J Mol Model. 2017 Aug 19;23(9):267. doi: 10.1007/s00894-017-3437-2.
10
Effects of PTCs on nonsense-mediated mRNA decay are dependent on PTC location.无义密码子对无义介导的mRNA降解的影响取决于无义密码子的位置。
Oncol Lett. 2017 Mar;13(3):1944-1948. doi: 10.3892/ol.2017.5627. Epub 2017 Jan 19.